Bröker M, Bäuml O, Göttig A, Ochs J, Bodenbenner M, Amann E
Research Laboratories of Behringwerke AG, Marburg, Federal Republic of Germany.
Appl Microbiol Biotechnol. 1991 Mar;34(6):756-64. doi: 10.1007/BF00169346.
The human blood coagulation protein Factor XIIIa (FXIIIa) was expressed in Saccharomyces cerevisiae employing Escherichia coli-yeast shuttle vectors based on a 2-mu plasmid. Several factors affecting high production yield of recombinant FXIIIa were analysed. The use of the regulatable GAL-CYC1 hybrid promoter resulted in higher FXIIIa expression when compared with the constitutive ADCI promoter. Screening for suitable yeast strains for expression of FXIIIa under the transcriptional control of the GAL-CYC1 hybrid promoter revealed a broad spectrum of productivity. No obvious correlation between the expression rate and the genetic markers of the strains could be identified. The medium composition markedly influenced the FXIIIa expression rates. The expression of FXIIIa was strictly regulated by the carbon source. Glucose as the only sugar and energy source repressed the synthesis of FXIIIa, whereas addition of galactose induced FXIIIa expression. Special feeding schemes resulted in a productivity of up to 100 mg FXIIIa/l in shake flasks.
利用基于2μm质粒的大肠杆菌-酵母穿梭载体在酿酒酵母中表达人血凝固蛋白因子XIIIa(FXIIIa)。分析了影响重组FXIIIa高产量的几个因素。与组成型ADCI启动子相比,使用可调节的GAL-CYC1杂交启动子可使FXIIIa表达更高。在GAL-CYC1杂交启动子的转录控制下筛选适合表达FXIIIa的酵母菌株,发现其生产力范围很广。未发现表达率与菌株遗传标记之间存在明显相关性。培养基组成显著影响FXIIIa表达率。FXIIIa的表达受到碳源的严格调控。葡萄糖作为唯一的糖和能量源会抑制FXIIIa的合成,而添加半乳糖则会诱导FXIIIa表达。特殊的补料方案在摇瓶中可使生产力达到100mg FXIIIa/l。